West Family Investments’s Takeda Pharmaceutical TAK Stock Holding History

West Family Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Buy	17,557 +1,951	+13%	+$32.3K	0.08%	351
2026 Q1	$289K	Buy	15,606 +599	+4%	+$10.5K	0.1%	181
2025 Q4	$234K	Sell	15,007 -22,850	-60%	-$327K	0.05%	308
2025 Q3	$554K	Buy	37,857 +1,650	+5%	+$24.5K	0.12%	157
2025 Q2	$560K	Buy	36,207 +2,739	+8%	+$40.5K	0.15%	143
2025 Q1	$498K	Hold	33,468	–	–	0.19%	109
2024 Q4	$443K	Buy	33,468 +15,638	+88%	+$215K	0.15%	136
2024 Q3	$254K	Buy	+17,830	New	+$253K	0.09%	235
2022 Q4	–	Sell	-21,318	Closed	-$276K	–	261
2022 Q3	$276K	Buy	21,318 +1,886	+10%	+$26.2K	0.11%	166
2022 Q2	$273K	Buy	19,432 +2,234	+13%	+$31.9K	0.11%	176
2022 Q1	$246K	Sell	17,198 -24,114	-58%	-$354K	0.07%	226
2021 Q4	$563K	Buy	41,312 +14,670	+55%	+$206K	0.15%	106
2021 Q3	$436K	Sell	26,642 -30,820	-54%	-$517K	0.11%	160
2021 Q2	$967K	Buy	+57,462	New	+$978K	0.26%	59

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

West Family Investments's TAK Position: Q2 2026 in Review

West Family Investments increased its Takeda Pharmaceutical (TAK) stake by 13% in Q2 2026, buying an estimated $32.3K and bringing the position to 17,557 shares worth $281K. The position accounts for 0.08% of the portfolio, ranked #351.

West Family Investments first reported a position in TAK in Q2 2021 and has held it in 14 quarters since. The position peaked at $967K in Q2 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

West Family Investments held 17,557 shares of Takeda Pharmaceutical worth $281K as of Q2 2026.
West Family Investments bought 1,951 Takeda Pharmaceutical shares in Q2 2026, an estimated $32.3K.
Takeda Pharmaceutical made up 0.08% of West Family Investments's portfolio in Q2 2026, its #351 holding.
West Family Investments first reported a position in Takeda Pharmaceutical in Q2 2021 and has held it in 14 quarters since.
West Family Investments's Takeda Pharmaceutical position peaked at $967K in Q2 2021.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.